by Ernie Mundell and Robin Foster Sanofi and GlaxoSmithKline announced Monday that their coronavirus vaccine candidate produced powerful responses in a preliminary trial that followed an earlier setback in the vaccine’s development. In selected data that has not yet been published in a peer-reviewed journal, the vaccine “triggered strong immune response amongst adults of all...
JANUARY 14, 2021 A single-shot COVID-19 vaccine from Johnson & Johnson has shown very strong results in early clinical trials, potentially providing a significant boost to U.S. vaccination efforts. The vaccine produced an immune response of all 805 clinical trial participants within two months of inoculation, according to results published Jan. 13 in the New England Journal of Medicine. The...
By Nick Lavars, October 05, 2020 Many cancer breath tests work by analyzing volatile organic compounds (VOCs) in the breath, which appear as unique patterns when our body’s metabolism is disrupted by the disease The pursuit of early-stage cancer screening methods that are both low-cost and non-invasive is a common goal among medical researchers, and a...
